These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 17145891

  • 1. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K, Exley MA, Jiang X, Ohkochi N, Taniguchi M, Seino K.
    Cancer Res; 2006 Dec 01; 66(23):11441-6. PubMed ID: 17145891
    [Abstract] [Full Text] [Related]

  • 2. Role of γδ T cells in α-galactosylceramide-mediated immunity.
    Paget C, Chow MT, Duret H, Mattarollo SR, Smyth MJ.
    J Immunol; 2012 Apr 15; 188(8):3928-39. PubMed ID: 22412194
    [Abstract] [Full Text] [Related]

  • 3. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Van Kaer L, Saiki I, Okumura K.
    Eur J Immunol; 2001 Jun 15; 31(6):1720-7. PubMed ID: 11385616
    [Abstract] [Full Text] [Related]

  • 4. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM, Palmer JL, Gamelli RL, Faunce DE.
    Shock; 2008 Feb 15; 29(2):269-77. PubMed ID: 17693934
    [Abstract] [Full Text] [Related]

  • 5. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A.
    Nat Med; 2001 Sep 15; 7(9):1057-62. PubMed ID: 11533711
    [Abstract] [Full Text] [Related]

  • 6. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S, Shimizu K, Hemmi H, Steinman RM.
    Immunol Rev; 2007 Dec 15; 220():183-98. PubMed ID: 17979847
    [Abstract] [Full Text] [Related]

  • 7. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K, Takeshima T, Kosaka A, Tsuji T, Matsuzaki J, Togashi Y, Ikeda H, Nishimura T.
    Immunol Lett; 2004 Aug 15; 95(1):5-11. PubMed ID: 15325792
    [Abstract] [Full Text] [Related]

  • 8. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.
    Biburger M, Tiegs G.
    J Leukoc Biol; 2008 Jul 15; 84(1):264-79. PubMed ID: 18407967
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide.
    Morishima Y, Ishii Y, Kimura T, Shibuya A, Shibuya K, Hegab AE, Iizuka T, Kiwamoto T, Matsuno Y, Sakamoto T, Nomura A, Taniguchi M, Sekizawa K.
    Eur J Immunol; 2005 Oct 15; 35(10):2803-14. PubMed ID: 16163669
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y, Uchida T, Inui T, Nakashima H, Fukasawa M, Seki S.
    Immunology; 2004 Sep 15; 113(1):35-43. PubMed ID: 15312134
    [Abstract] [Full Text] [Related]

  • 12. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K, Kinjo Y, Yara S, Uezu K, Koguchi Y, Tohyama M, Azuma M, Takeda K, Akira S, Saito A.
    Infect Immun; 2001 Nov 15; 69(11):6643-50. PubMed ID: 11598033
    [Abstract] [Full Text] [Related]

  • 13. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.
    Fujii S, Shimizu K, Kronenberg M, Steinman RM.
    Nat Immunol; 2002 Sep 15; 3(9):867-74. PubMed ID: 12154358
    [Abstract] [Full Text] [Related]

  • 14. [Repeated administration of alpha-galactosyl ceramide attenuates of natural killer T cells].
    Minagawa M, Iiai T, Sato Y, Yamamoto S, Hatakeyama K.
    Gan To Kagaku Ryoho; 2005 Oct 15; 32(11):1553-5. PubMed ID: 16315866
    [Abstract] [Full Text] [Related]

  • 15. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
    Ikarashi Y, Iizuka A, Heike Y, Yoshida M, Takaue Y, Wakasugi H.
    Immunol Lett; 2005 Nov 15; 101(2):160-7. PubMed ID: 16054231
    [Abstract] [Full Text] [Related]

  • 16. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Kitamura H, Ohta A, Sekimoto M, Sato M, Iwakabe K, Nakui M, Yahata T, Meng H, Koda T, Nishimura S, Kawano T, Taniguchi M, Nishimura T.
    Cell Immunol; 2000 Jan 10; 199(1):37-42. PubMed ID: 10675273
    [Abstract] [Full Text] [Related]

  • 17. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation.
    Cullen R, Germanov E, Shimaoka T, Johnston B.
    J Immunol; 2009 Nov 01; 183(9):5807-15. PubMed ID: 19812206
    [Abstract] [Full Text] [Related]

  • 18. Valpha14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes.
    Ohtaki H, Ito H, Ando K, Ishikawa T, Saito K, Imawari M, Yokochi T, Moriwaki H, Seishima M.
    Biochem Biophys Res Commun; 2009 Jan 16; 378(3):579-83. PubMed ID: 19056341
    [Abstract] [Full Text] [Related]

  • 19. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    Burdin N, Brossay L, Koezuka Y, Smiley ST, Grusby MJ, Gui M, Taniguchi M, Hayakawa K, Kronenberg M.
    J Immunol; 1998 Oct 01; 161(7):3271-81. PubMed ID: 9759842
    [Abstract] [Full Text] [Related]

  • 20. Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.
    Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Yamamoto M, Fujita Y, Miyagi T, Ohkawa K, Hayashi N.
    J Hepatol; 2008 Nov 01; 49(5):779-86. PubMed ID: 18760855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.